https://www.prnewswire.com/news-releases/inimmune-announces-first-cancer-patient-dosed-in-phase-1-clinical-study-using-the-immunotherapeutic-ini-4001-a-novel-tlr78-agonist-302204890.html
/PRNewswire/ -- Inimmune, a clinical stage biotech company focused on the development of novel immunotherapies, vaccines, and vaccine adjuvants announced...
cancer patientin phaseannouncesfirstdosed
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1374963/full
Acute myeloid leukemia (AML) is a severe hematological malignancy with poor outcomes, particularly in older adults. Traditional treatment options like high-d...
frontiersupdatesnovelimmunotherapeuticstrategies